Stephen David Prior An2 Therapeutics, Inc. (ANTX) insider trading activity

ANTX Quotes by TradingView

Stephen David Prior is Chief Strategy Officer of AN2 Therapeutics, Inc.. Currently has a direct ownership of 61,313 shares of ANTX, which is worth approximately $80,320. The most recent transaction as insider was on Feb 26, 2025, when has been sold 28,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.3K
73.48% 3M change
n/a 12M change
Total Value Held $80,320

Stephen David Prior Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2025
BUY
Grant, award, or other acquisition
-
28,000 Added 31.35%
61,313 Common Stock
Jan 03 2025
SELL
Open market or private sale
$2,718 $1.34 p/Share
2,029 Reduced 5.74%
33,313 Common Stock
Nov 04 2024
BUY
Grant, award, or other acquisition
-
10,125 Added 22.27%
35,342 Common Stock
SDP

Stephen David Prior

Chief Strategy Officer
Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANTX